Holdings

Rosalind Advisors, Inc.

As of Sep 30, 2026, Rosalind Advisors, Inc. reported 31 positions worth US$295M. Largest: Delcath Systems, Inc., Verastem, Inc. and Fennec Pharmaceuticals Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Delcath Systems, Inc.3.3MUS$52.7Mno changeSep 30, 2026
Verastem, Inc.4.24MUS$34.1M+250KSep 30, 2026
Fennec Pharmaceuticals Inc.3.19MUS$34Mno changeSep 30, 2026
Xeris Biopharma Holdings, Inc.2.58MUS$24.7M−326KSep 30, 2026
Cybin, Inc.1.39MUS$17.1M−569KSep 30, 2026
Savara, Inc.3.18MUS$16.4Mno changeSep 30, 2026
Replimune Group, Inc.1MUS$13.2MnewSep 30, 2026
Vor Biopharma Inc.609KUS$11.6M−39,401Sep 30, 2026
X4 Pharmaceuticals, Inc.3.21MUS$9.32Mno changeSep 30, 2026
Aquestive Therapeutics, Inc.2MUS$9.26M+1.75MSep 30, 2026